Personalized RT Doubles Survival in Advanced HCC

(MedPage Today) -- Use of personalized rather than standard dosimetry significantly improved objective responses and more than doubled overall survival in patients with unresectable, locally advanced hepatocellular carcinoma undergoing selective...